CD274 and neoplasm: The expression levels of Programmed Cell Death-Ligand 1 (PD-L1), tumor mutational burden (TMB), tumor-infiltrating lymphocytes (TILs) and gene expression profiles (GEP) are all recognized for their predictive role in the treatment of NSCLC with ICI, but all have its limitations (4, 5).